Frankfurt - Delayed Quote EUR
BridgeBio Pharma, Inc. (2CL.F)
32.81
-0.64
(-1.91%)
As of 3:51:51 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-500,424
-520,726
-527,720
-419,494
-497,934
Investing Cash Flow
36,433
60,781
54,033
453,147
-200,826
Financing Cash Flow
529,237
748,457
451,535
-13,134
736,446
End Cash Position
542,742
683,244
394,732
416,884
396,365
Interest Paid Supplemental Data
79,298
91,342
61,108
54,443
29,774
Capital Expenditure
-9,011
-8,908
-1,306
-6,321
-48,246
Issuance of Capital Stock
-513
314,741
449,810
4,852
--
Issuance of Debt
1,075,000
950,000
--
--
1,203,796
Repayment of Debt
-459,000
-473,417
--
-20,486
-124,119
Repurchase of Capital Stock
-54,642
-7,526
-6,880
-1,561
-204,746
Free Cash Flow
-509,435
-529,634
-529,026
-425,815
-546,180
12/31/2021 - 7/2/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade